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Abstract
Based on the results obtained from 1995 to 
2009, we explored the current activity statuses of 
the uterine cervix cancer screening by 
examination car conducted in Niigata Prefecture. 
A total of 318,580 women between age 20 and 
85 (60,215 initial examinees including examinees 
who received cancer screening at interval of more 
than 3 or 5 years, and 258,365 re-examinees who 
received the screening more than twice within the 
past 3 or 5 years) were screened during this 15-
year period. The mean consultation rate 
(proportion of examinees to the target population) 
was 4.10%, showing the highest rate 5.50% in 
1996 and the lowest rate 1.98% in 2007. By the 
cancer screening, 255 cancer patients were 
detected in the 15 years (mean detection rate: 
0.08%, range: 0.04% -1.30%). The mean cancer 
detection rate in the initial examinees (0.28%, 
167 cases) was 8.1 times higher than that in the 
re-examinees (0.03%, 88 cases). Furthermore, the 
frequency of examinees diagnosed with dysplasia 
in the initial examinees was 5.7 times higher than 
that in the re-examinees (0.51% vs. 0.09%). 
Examinees requiring detailed examination 
(3.27%), or examinees diagnosed with dysplasia 
(0.18%), were detected at the highest rate in their 
twenties. However, the overall cancer detection 
rate in their twenties (0.17%) was the second-
highest during the study period, after that in their 
thirties (0.24%). 
The cancer detection rate leveled off at about 
0.08% during the 15 years, and higher detection 
rates were found in the initial examinees, 
especially in their twenties and thirties. We 
believe the increase in cancer screening 
examinees of these generations is related to the 
increase in detection rates of dysplasia or cancer, 
and may be implicated in the future decrease in 
the cervical cancer death rate.
Introduction
In recent years, the national annual average of 
the age-adjusted mortality rate for uterine cancer 
including cervical cancer and corpus cancer in 
Japanese women has remained flat at 4.1 ± 
0.1/100,000 women. As shown in Fig. 1, the age-
adjusted uterine cancer mortality rates in Niigata 
Prefecture from 1995 to 2009 were lower than the 
national average, but the rate increased slowly 
during those 15 years and recently reached the 
national average. Since cases of uterine cervix 
cancer account for 80% of the total uterine cancer 
cases, the increase in the mortality rate from 
uterine cancer may reflect the increase in the rate 
of uterine cervix cancer. 
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The uterine cervix cancer screening in Niigata 
Prefecture started in 1968 as part of a program of 
cancer prevention measures. As a result, cancer 
screening is now firmly entrenched as one of the 
health services provided to residents of Niigata 
Prefecture. The screening has been conducted in 
two ways; one is by examination car, and the 
other is by a visit to a medical office. In 1982, the 
Health and Medical Service Act for the Aged was 
enacted in Japan, and the responsibilities of the 
nation's healthcare system were stipulated 
explicitly. This ensured that cancer screening 
would become pervasive throughout the country1). 
However, the consultation rate (proportion of 
examinees to the target population) began to 
decline in 1995 as examinees aged and became 
less mobile2). This tendency was shown even 
more clearly after 1998 because the government 
changed the nation's measures and policies for 
cancer screening3).
On the other hand, the government took 
responsibility for examining women more than 20 
years old in 2004 because the development of 
cervix cancer has increased in younger 
generation4). At about the same time, the Japan 
Society of Obstetrics and Gynecology introduced 
the Bethesda System for reporting the results of 
cervical cytology, to improve cancer detection 
rates5). The government started the Fundamental 
Plan for Cancer Control to increase the 
consultation rate, and a cancer screening free 
coupon was distributed in 20096).
Uterine cervix cancer screening by cytological 
examination is an appropriate program that lends 
itself to statistical evaluation. Previous studies 
reported that the uterine cervix cancer mortality 
rate can be decreased when examinees receive 
regular screening. However, reports on the current 
Fig. 1  Age-adjusted uterine cancer mortality rate in Niigata Prefecture compared with the national 
average
         Data are shown as the mortality rate per 100,000 women between 1995 and 2009.
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status of cancer screening in Niigata Prefecture or 
on the issues related to cancer screening are very 
few. We therefore explored the current status of 
the consultation rates and cancer detection rate 
based on the uterine cervix cancer screening 
results by year and age group obtained from 1995 
to 2009. In addition to examining the current 
status of cancer screening, we considered the 
problems in cancer screening and propose the 
necessary measures to increase the consultation 
rate. 
Subjects and methods
1. Subjects
The study subjects were 318,580 women who 
received cancer screening by examination car 
from 1995 to 2009. Of the total examinees, 
60,215 (18.9%) was initial examinees including 
examinees who received cancer screening at 
interval of more than 3 or 5 years, and 258,365 
(81.1%) was re-examinees who received the 
cancer screening more than twice within the past 
3 or 5 years. The cancer screening was carried out 
for residents of Niigata Prefecture by the Niigata 
Health Service Center. 
2. Screening
Both history taking and cytological 
examination of the uterine cervix were conducted 
for each examinee. History taking included the 
following items: age, history of pregnancy and 
childbirth, menstrual status and menstrual cycle, 
presence or absence of hormone treatment, 
presence of symptoms such as irregular vaginal 
bleeding within 6 months, and history and results 
of previous medical examination.
The collection and preparation of smears for 
cytological examination was conducted as 
follows: the specimen cells were scraped from the 
cervix and vaginal surface and then fixed to a 
slide, stained with Papanicolaou stain, and 
examined under a microscope. All smears were 
classified by the Nichibo classification (class I, II, 
IIIa, IIIb, IV, and V)7). When a smear of class IIIb, 
IV, or V was found, the examinee received a 
detailed examination.
Results
Table 1 shows the true state of the cancer 
screening by examination car in Niigata 
Prefecture from 1995 to 2009. Of the target 
population of 7,764,880 in the 15 years, 318,580 
women participated in the screening. The mean 
consultation rate in the 15 years was 4.10%. The 
highest number of examinees, 26,820, was found 
in 1996, and after that the number decreased until 
2007. The number of examinees requiring 
detailed examination by cytological examination 
was 68 in 1995, and it increased to 193 in 2009. 
The number of examinees diagnosed with 
dysplasia was 546 (0.17%) in the 15 years, with a 
detection rate of more than 0.30% since 2006. A 
total of 255 cancer patients were detected in the 
15 years, showing a mean detection rate of 0.08%, 
and a range from 0.04% in 1996 to 0.13% in 
2008. The cancer detection rate remained flat at 
about 0.08% during the 15 years. 
Table 2 shows the results of the uterine cervix 
cancer screening by year. The mean frequencies 
of examinees requiring detailed examination, 
examinees diagnosed with dysplasia, and 
examinees diagnosed with cancer were higher in 
the initial examinees than in the re-examinees 
(1.25% vs. 0.24%, 0.51% vs. 0.24%, 0.09%, and 
0.28% vs. 0.03%, respectively). In the initial 
examinees, the frequency of examinees requiring 
detailed examination in 2009 (2.42%) was about 
4.5 times higher than that in 1995 (0.54%). In the 
re-examinees, the frequency increased about 
twice, from 0.21% to 0.45%, during the same 
period. The number of examinees diagnosed with 
dysplasia in the initial examinees and the re-
examinees were 310 (0.51%) and 236 (0.09%), 
respectively. The mean cancer detection rate in 
the initial examinees (0.28%) was about 8.1 times 
higher than that in the re-examinees (0.03%). 
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Table 1 Uterine cervix cancer screening practice in Niigata Prefecture from 1995 to 2009
Year Targetpopulation
Number of 
examinees (%)
Examinees requiring 
detailed examination (%)
Examinees diagnosed
with dysplasia (%)
Examinees diagnosed 
with cancer (%)
1995  484,406 26,131 (5.39) 68 (0.26) 20 (0.08) 14 (0.05)
1996  487,551 26,820 (5.50) 42 (0.16) 18 (0.07) 12 (0.04)
1997  479,663 25,039 (5.22) 69 (0.28) 30 (0.12) 19 (0.08)
1998  484,706 23,495 (4.85) 53 (0.23) 17 (0.07) 19 (0.07)
1999  488,633 21,935 (4.49) 55 (0.25) 15 (0.07) 15 (0.07)
2000  492,205 22,295 (4.53) 74 (0.33) 34 (0.15) 13 (0.06)
2001  495,644 24,014 (4.85) 63 (0.26) 34 (0.14) 17 (0.07)
2002  499,575 23,210 (4.65) 83 (0.36) 28 (0.12) 22 (0.09)
2003  513,940 24,406 (4.75) 135 (0.55) 44 (0.18) 33 (0.12)
2004  516,802 23,450 (4.54) 103 (0.44) 42 (0.18) 17 (0.07)
2005  658,100 16,751 (2.55) 88 (0.53) 46 (0.27) 16 (0.10)
2006  742,260 16,354 (2.20) 114 (0.70) 54 (0.33) 12 (0.07)
2007  694,157 13,758 (1.98) 109 (0.79) 56 (0.41) 13 (0.09)
2008  364,366 14,335 (3.93) 132 (0.92) 56 (0.39) 19 (0.13)
2009  362,872 16,587 (4.57) 193 (1.16) 52 (0.31) 14 (0.08)
Total (%) 7,764,880 318,580 (4.10)a 1,381 (0.43)b 546 (0.17)c 255 (0.08)d
a: Consultation rate (Percentage of the target population).
b: Rate of examinees requiring detailed examination (Percentage of the examinees).
c: Rate of examinees diagnosed with dysplasia (Percentage of the examinees).
d: Cancer detection rate (Percentage of the examinees).
Table 2 Results of uterine cervix cancer screening by year
Year
Initial examinees Re-examinees
Number of 
examinees
Number of examinees by result (%)
Number of 
examinees
Number of examinees by result (%)
Examinees requiring 
detailed examination
Examinees diagnosed 
with dysplasia
Examinees diagnosed 
with cancer
Examinees requiring 
detailed examination
Examinees diagnosed 
with dysplasia
Examinees diagnosed 
with cancer
1995 3,902 21 (0.54) 6 (0.15) 6 (0.15) 22,229 47 (0.21) 14 (0.06) 8 (0.04)
1996 4,570 21 (0.46) 7 (0.15) 7 (0.15) 22,250 21 (0.09) 11 (0.05) 5 (0.02)
1997 4,084 23 (0.56) 10 (0.24) 9 (0.22) 20,955 46 (0.22) 20 (0.10) 10 (0.05)
1998 3,578 27 (0.75) 7 (0.20) 12 (0.34) 19,917 26 (0.13) 10 (0.05) 7 (0.04)
1999 3,051 23 (0.75) 6 (0.20) 11 (0.36) 18,884 32 (0.17) 9 (0.05) 4 (0.02)
2000 3,501 35 (1.00) 17 (0.49) 10 (0.29) 18,794 39 (0.21) 17 (0.09) 3 (0.02)
2001 4,748 33 (0.70) 19 (0.40) 9 (0.19) 19,266 30 (0.16) 15 (0.08) 8 (0.04)
2002 4,160 43 (1.03) 14 (0.34) 18 (0.43) 19,050 40 (0.21) 14 (0.07) 4 (0.02)
2003 4,613 67 (1.45) 21 (0.46) 24 (0.52) 19,793 68 (0.34) 23 (0.12) 9 (0.05)
2004 4,108 39 (0.95) 19 (0.46) 10 (0.24) 19,342 64 (0.33) 23 (0.12) 7 (0.04)
2005 3,341 55 (1.65) 31 (0.93) 10 (0.30) 13,410 33 (0.25) 15 (0.11) 6 (0.04)
2006 3,810 69 (1.81) 34 (0.89) 9 (0.24) 12,544 45 (0.36) 20 (0.16) 3 (0.02)
2007 3,307 72 (2.18) 37 (1.12) 9 (0.27) 10,451 37 (0.35) 19 (0.18) 4 (0.04)
2008 3,415 77 (2.25) 41 (1.20) 10 (0.29) 10,920 55 (0.50) 15 (0.14) 9 (0.08)
2009 6,027 146 (2.42) 41 (0.68) 13 (0.22) 10,560 47 (0.45) 11 (0.10) 1 (0.01)
Total 60,215 751 (1.25) 310 (0.51) 167 (0.28) 258,365 630 (0.24) 236 (0.09) 88 (0.03)
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Table 3 shows the change in the cytological 
classification by year. Of all the examinees, 
317,199 women (99.57%) were classified as class 
I (240,630 women, 75.53%) or II (76,569 women, 
24.03%). The number of examinees classified as 
class IIIa or higher were as follows: IIIa: 895 
(0.28%), IIIb: 220 (0.07%), IV: 170 (0.05%), V: 
96 (0.03%). The frequency of the examinees 
classified as class IIIa or higher showed an 
increasing trend from 0.70% of 2006. 
Table 4 shows the results of the cytological 
classification by age. The frequency of the 
examinees classified as class IIIa or higher was as 
follows: 77 (3.27%) in their twenties, 361 
(1.06%) in their thirties, 354 (0.61%) in their 
forties, 219 (0.28%) in their fifties, 232 (0.24%) 
in their sixties, and 126 (0.28%) in their seventies. 
The frequency of the examinees classified as class 
IIIa or higher decreased with increasing age, and 
the highest rate was found in their twenties. 
Table 3 Change in the cytological classification by year
Year I  (%) II  (%) IIIa  (%) IIIb  (%) IV  (%) V  (%) Total
1995 21,193 (81.10) 4,870 (18.64) 40 (0.15) 14 (0.05) 10 (0.04) 4 (0.02) 26,131
1996 21,557 (80.38) 5,221 (19.47) 23 (0.09) 12 (0.04) 5 (0.02) 2 (0.01) 26,820
1997 19,774 (78.97) 5,196 (20.75) 31 (0.12) 15 (0.06) 20 (0.08) 3 (0.01) 25,039
1998 17,887 (76.13) 5,555 (23.64) 28 (0.12) 14 (0.06) 5 (0.02) 6 (0.03) 23,495
1999 16,785 (76.52) 5,095 (23.23) 33 (0.15) 13 (0.06) 6 (0.03) 3 (0.01) 21,935
2000 16,740 (75.08) 5,481 (24.58) 41 (0.18) 12 (0.05) 10 (0.04) 11 (0.05) 22,295
2001 17,344 (72.22) 6,607 (27.51) 34 (0.14) 11 (0.05) 7 (0.03) 11 (0.05) 24,014
2002 16,660 (71.78) 6,467 (27.86) 56 (0.24) 11 (0.05) 14 (0.06) 2 (0.01) 23,210
2003 17,058 (69.89) 7,213 (29.55) 95 (0.39) 14 (0.06) 19 (0.08) 7 (0.03) 24,406
2004 16,759 (71.47) 6,588 (28.09) 63 (0.27) 21 (0.09) 12 (0.05) 7 (0.03) 23,450
2005 11,963 (71.42) 4,700 (28.06) 65 (0.39) 9 (0.05) 7 (0.04) 7 (0.04) 16,751
2006 12,228 (74.77) 4,012 (24.53) 82 (0.50) 16 (0.10) 5 (0.03) 11 (0.07) 16,354
2007 11,074 (80.49) 2,575 (18.72) 75 (0.55) 13 (0.09) 12 (0.09) 9 (0.07) 13,758
2008 11,044 (77.04) 3,159 (22.04) 84 (0.59) 28 (0.20) 16 (0.11) 4 (0.03) 14,335
2009 12,564 (75.75) 3,830 (23.09) 145 (0.87) 17 (0.10) 22 (0.13) 9 (0.05) 16,587
Total 240,630 (75.53) 76,569 (24.03) 895 (0.28) 220 (0.07) 170 (0.05) 96 (0.03) 318,580 
All smears were classified by the Nichibo classification (class I, II, IIIa, IIIb, IV, and V).
Table 4 Results of the cytological classification by age
Age I (%) II (%) IIIa (%) IIIb (%) IV (%) V (%) Total
20-29 2,070 (87.82) 210 (8.91) 64 (2.72) 8 (0.34) 5 (0.21) 0 (0.00) 2,357
30-39 31,976 (94.07) 1,653 (4.86) 228 (0.67) 64 (0.19) 51 (0.15) 18 (0.05) 33,990
40-49 53,980 (92.74) 3,872 (6.65) 231 (0.40) 61 (0.10) 38 (0.07) 24 (0.04) 58,206
50-59 56,744 (72.63) 21,163 (27.09) 134 (0.17) 32 (0.04) 36 (0.05) 17 (0.02) 78,126
60-69 64,152 (65.57) 33,459 (34.20) 151 (0.15) 31 (0.03) 26 (0.03) 24 (0.02) 97,843
70-79 29,736 (65.82) 15,314 (33.90) 81 (0.18) 21 (0.05) 14 (0.03) 10 (0.02) 45,176
80- 1,972 (68.42) 898 (31.16) 6 (0.21) 3 (0.10) 0 (0.00) 3 (0.01) 2,882
Total 240,630 (75.53) 76,569 (24.03) 895 (0.28) 220 (0.07) 170 (0.05) 96 (0.03) 318,580
All smears were classified by the Nichibo classification (class I, II, IIIa, IIIb, IV, and V).
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However, none of the women in their twenties 
were classified as class V. 
Table 5 shows the cancers detected by 
cytological examination by age. The frequency of 
carcinoma in situ accounted for 75.69% of all 255 
detected cancers. The frequency of squamous cell 
carcinoma was 11.37%. Adenocarcinoma of the 
cervix (14 cases, 5.49%), endometrial carcinoma 
(10 cases, 0.07%), adenosquamous carcinoma (2 
cases, 0.05%), ovarian cancer (1 case, 0.39%), 
vaginal cancer (1 case, 0.39%), metastatic cancer 
(1 case, 0.39%), and other cancers (4 cases, 
1.57%) were detected by the screening during the 
15 years surveyed. Four cases detected in their 
twenties were all carcinoma in situ. Carcinoma in 
situ or squamous cell carcinoma was detected 
with a high frequency in their thirties (27.84%) 
and forties (21.96%), or in their sixties (3.53%), 
respectively. 
Discussion
The cancer detection rate revealed by the 
screening in Niigata Prefecture maintained almost 
the same value of 0.08% on average for the 15 
years surveyed, although the consultation rate for 
uterine cervix cancer screening decreased every 
year from 1996 to 2007. The cancer detection rate 
in the initial examinees was 8.1 times higher than 
that in the re-examinees. The similarity of the 
cancer detection rate from 1995 to 2009 may 
result mainly from the detection of the examinees 
diagnosed with cancer from the initial examinees.
The age-adjusted uterine cervix cancer 
mortality rate in Japan has remained at 4.1 ± 
0.1/100,000 women since 1995. Although the rate 
in Niigata Prefecture was only 2.0/100,000 
women in 1995, it increased after that, and 
reached to the national average in 2007. Recently, 
it has continued to be flat at a level of 4.0/100,000 
women. In Niigata Prefecture, as part of the 
cancer prevention program, screening for uterine 
cervix cancer has been conducted since 1968, but 
the increase in the uterine cervix cancer mortality 
rate of recent years may be ineffective in 
preventing the cancer by the screening. Therefore, 
we analyzed the results obtained by the screening 
from 1995 through 2009, and examined the 
fluctuations of the consultation rate and the 
cancer mortality rate. 
The consultation rate of cancer screening by 
examination car in Niigata Prefecture exhibited a 
declining trend until 2007. Because the lowest 
mortality rate of uterine cervix cancer 
(4.2/100,000 women) was shown in 2007, the 
decrease in the consultation rate may be related to 
the increase in the mortality rate.
In the initial examinees, the number of women 
requiring detailed examination was 5.1 times 
higher than that in the re-examinees. Moreover, 
the dysplasia and cancer detection rates in the 
Table 5 Cancers detected by histopathological diagnosis by age
Age
Carcinoma 
in situ
Squamous cell 
carcinoma 
Adenocarcinoma 
(Cervix)
Endometrial 
carcinoma
Adenosquamous 
carcinoma
Ovarian 
cancer
Vaginal 
cancer
Metastatic 
acncer
Others Total
20-29 4  (  1.57) 0  (  0.00) 0  (0.00) 0  (0.00) 0  (0.00) 0  (0.00) 0  (0.00) 0  (0.00) 0  (0.00) 4
30-39 71  (27.84) 6  (  2.35) 2  (0.78) 0  (0.00) 1  (0.39) 0  (0.00) 0  (0.00) 0  (0.00) 1  (0.39) 81
40-49 56  (21.96) 7  (  2.75) 4  (1.57) 0  (0.00) 0  (0.00) 0  (0.00) 0  (0.00) 0  (0.00) 1  (0.39) 68
50-59 21  (  8.24) 5  (  1.96) 3  (1.18) 5  (1.96) 0  (0.00) 0  (0.00) 0  (0.00) 0  (0.00) 2  (0.78) 36
60-69 26  (10.20) 9  (  3.53) 4  (1.57) 5  (1.96) 1  (0.39) 1  (0.39) 1  (0.39) 1  (0.39) 0  (0.00) 48
70-79 14  (  5.49) 1  (  0.39) 1  (0.39) 0  (0.00) 0  (0.00) 0  (0.00) 0  (0.00) 0  (0.00) 0  (0.00) 16
80- 1  (  0.39) 1  (  0.39) 0  (0.00) 0  (0.00) 0  (0.00) 0  (0.00) 0  (0.00) 0  (0.00) 0  (0.00) 2
Total (%) 193  (75.69) 29  (11.37) 14  (5.49) 10  (0.07) 2  (0.05) 1  (0.39) 1  (0.39) 1  (0.39) 4  (1.57) 255
Percentages of all 255 detected cancers are shown in parentheses.
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initial examinees were 8.1 and 5.1 times higher, 
respectively, than those in the re-examinees. The 
progression of cervix tumor is relatively slow8). 
The examinees requiring detailed initial 
examination after  the screening were 
professionally managed in a medical facility. For 
this reason, patients with cancer are usually 
detected during the initial screening or are 
patients who stopped being managed at a medical 
facility. As shown in the results obtained for the 
15 years surveyed, the examinees requiring 
detailed examination and the examinees 
diagnosed with dysplasia were detected at the 
highest rates among initial examinees in their 
twenties. The consultation rate of the cancer 
screening in young people has increased in recent 
years since the Ministry of Health decided to 
change the fiscal target screening age from “30 
years old and over” to “20 years old and over” in 
2004. This trend also gained momentum because 
a free coupon for cervical cancer screening was 
distributed to women who reached 20, 25, 30, 35, 
and 40 years old9). However, the consultation rate 
in young people is still low. In Niigata Prefecture, 
the highest number of cancer screenings for 
women in their twenties was 622 in 2009, and 
was only 4.0% of all the examinees10).
Since a decrease in age at first sexual 
intercourse has occurred in recent years, uterine 
cervix cancer is likely to appear more commonly 
among increasingly younger people. However, 
three researchers have pointed out that the 
diffusion of the right knowledge about cervical 
cancer is still not promoted to young people11-13). 
An increase in the consultation rate among young 
people will enhance the preventive effect of 
cancer screening in the future.
Uterine cervix cancer screening is a secondary 
preventive measure aimed at the early detection 
and rapid cure of this cancer. However, people's 
attention is currently focused on the primary 
preventive measure, vaccination. The association 
between human papillomavirus (HPV) infection 
and the development of uterine cervix cancer was 
reported in 197414), and the anticancer effect of 
the vaccination has been demonstrated15). The 
administration of the vaccine against HPV has 
already started in more than 80 countries16). The 
vaccination was approved by the Japanese 
Government in Oct. 2009, and vaccinations were 
started in general healthcare facilities in Dec. 
200917). As the primary measure for uterine cervix 
cancer prevention, the vaccination may be helpful 
to decrease the mortality rate. 
In summary, the consultation rate of uterine 
cervix cancer screening in Niigata Prefecture has 
decreased since 1996, but it has been increasing 
recently because of the increase in the number of 
young women who are initial examinees. The rate 
of examinees requiring detailed examination and 
the dysplasia and cancer detection rates were 
higher in the initial examinees compared with the 
re-examinees. Promoting the diffusion of 
knowledge about uterine cervix cancer to 
adolescents and increasing the number of initial 
examinees may contribute to decreasing the 
mortality rate of cervical cancer in the future. 
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